Page last updated: 2024-12-11

syringin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

syringin: a phenylpropanoid glycoside; see also eleutherosides & lyoniside for eleutheroside A: 474-58-8 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

syringin : A monosaccharide derivative that is trans-sinapyl alcohol attached to a beta-D-glucopyranosyl residue at position 1 via a glycosidic linkage. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5316860
CHEMBL ID250872
CHEBI ID9380
SCHEMBL ID409032
MeSH IDM0091250

Synonyms (78)

Synonym
methoxyconiferine
syringinenin
ligustrin
syrigin
(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-[4-[(e)-3-hydroxyprop-1-enyl]-2,6-dimethoxy-phenoxy]tetrahydropyran-3,4,5-triol
syringoside
nsc287441
.beta.-d-glucopyranoside, 4-(3-hydroxy-1-propenyl)-2,6-dimethoxyphenyl
magnolenin a
.beta.-terpineol
lilacin
4-o-(beta-d-glucosyl)-trans-4-sinapyl alcohol
CHEBI:9380 ,
4-[(1e)-3-hydroxyprop-1-en-1-yl]-2,6-dimethoxyphenyl beta-d-glucopyranoside
NCGC00180873-01
nsc-287441
syringenin
MEGXP0_000264
MLS000574917
smr000156227
C01533
sinapyl alcohol-4-o-beta-d-glucopyranoside
eleutheroside b
syringin
118-34-3
ligustrin (van)
nsc 287441
glucoside, 4-(3-hydroxypropenyl)-2,6-dimethoxyphenyl, d
beta-d-glucopyranoside, 4-(3-hydroxy-1-propenyl)-2,6-dimethoxyphenyl
ACON1_000108
bdbm50241356
CHEMBL250872 ,
BMSE000613
sinapyl alcohol 4-o-glucoside
(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-[4-[(e)-3-hydroxyprop-1-enyl]-2,6-dimethoxyphenoxy]oxane-3,4,5-triol
(2s,3r,4s,5s,6r)-2-[2,6-dimethoxy-4-[(e)-3-oxidanylprop-1-enyl]phenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
A803915
2-(hydroxymethyl)-6-[4-[(e)-3-hydroxyprop-1-enyl]-2,6-dimethoxyphenoxy]oxane-3,4,5-triol
HMS2217D04
S3841
magmolenin a
unii-i6f5b11c96
beta-d-glucopyranoside, 4-((1e)-3-hydroxy-1-propenyl)-2,6-dimethoxyphenyl
i6f5b11c96 ,
ilexanthin a
magnolenin
AKOS015912605
SCHEMBL409032
syringin [mi]
eleutheroside b [usp-rs]
eleutheroside b (constituent of eleuthero) [dsc]
4-((1e)-3-hydroxy-1-propen-1-yl)-2,6-dimethoxyphenyl-.beta.-d-glucopyranoside
Q-100086
(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-(4-((e)-3-hydroxyprop-1-en-1-yl)-2,6-dimethoxyphenoxy)tetrahydro-2h-pyran-3,4,5-triol
DTXSID2042438 ,
eleutheroside b, analytical standard
eleutheroside b, united states pharmacopeia (usp) reference standard
alyposide
methoxyconiferin
mfcd00016778
HY-N0824
(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-(4-((e)-3-hydroxyprop-1-enyl)-2,6-dimethoxyphenoxy)tetrahydro-2h-pyran-3,4,5-triol
syringin,(s)
eleutheroside-b
Q891785
HMS3885E08
CCG-268321
nsc-791584
nsc791584
CS-0009856
i(2)-d-glucopyranoside, 4-[(1e)-3-hydroxy-1-propen-1-yl]-2,6-dimethoxyphenyl
(e)-4-[-3-hydroxy-1-propenyl]-2,6-dimethoxyphenyl-beta-d-glucopyranoside
4-((1e)-3-hydroxy-1-propen-1-yl)-2,6-dimethoxyphenyl-beta-d-glucopyranoside
eleutheroside b (usp-rs)
dtxcid0022438
eleutheroside b (constituent of eleuthero)
4-((1e)-3-hydroxyprop-1-en-1-yl)-2,6-dimethoxyphenyl beta-d-glucopyranoside
4-o-(beta-d-glucosyl)-trans-4-sinapoyl alcohol

Research Excerpts

Overview

Syringin (SYR) is an active substance isolated from Acanthopanax senticosus plants. Syringin is a bioactive compound with anti-inflammation, antioxidant, as well as neuroprotective effects.

ExcerptReferenceRelevance
"Syringin is a natural chemical compound first isolated from the bark of lilac and is known to have neuroprotective effects in middle cerebral artery occlusion (MCAO). "( Syringin inhibits endogenous volume regulated anion channel currents of HEK293 cells in hypotonic circumstances.
Huang, L; Liang, M; Lu, L; Wang, J; Wang, S; Xu, Z; Yao, W; Zhu, N, 2023
)
3.8
"Syringin (SYR) is an active substance isolated from Acanthopanax senticosus plants, and possesses anti-inflammatory and neuroprotective properties."( Syringin exerts neuroprotective effects in a rat model of cerebral ischemia through the FOXO3a/NF-κB pathway.
Cao, J; Jiang, N; Luo, J; Meng, C; Tan, J; Zhao, J, 2021
)
2.79
"Syringin is a bioactive compound with anti-inflammation, antioxidant, as well as neuroprotective effects."( Syringin protects against cerebral ischemia/reperfusion injury via inhibiting neuroinflammation and TLR4 signaling.
Liu, Y; Tan, Z; Tong, X; Zhu, X, 2022
)
2.89
"Syringin is an active principle purified from the rhizome and root parts of Eleutherococcus senticosus (Araliaceae). "( Role of sympathetic tone in the loss of syringin-induced plasma glucose lowering action in conscious Wistar rats.
Hsu, FL; Liu, IM; Niu, HS, 2008
)
2.06

Treatment

Syringin-treated mice also showed markedly elevated adiponectin production in EAT and suppressed expression of pro-inflammatory cytokines in peripheral tissues. Syringin treatment of hepatocytes isolated from STZ-diabetic rats enhanced glycogen synthesis.

ExcerptReferenceRelevance
"Syringin-treated mice also showed markedly elevated adiponectin production in EAT and suppressed expression of pro-inflammatory cytokines in peripheral tissues, indicating a significant reduction in low-grade chronic inflammation."( Syringin attenuates insulin resistance via adiponectin-mediated suppression of low-grade chronic inflammation and ER stress in high-fat diet-fed mice.
Hyun, CK; Kim, B; Kim, MS, 2017
)
2.62
"Syringin treatment of hepatocytes isolated from STZ-diabetic rats enhanced glycogen synthesis ."( Hypoglycemic effect of syringin from Eleutherococcus senticosus in streptozotocin-induced diabetic rats.
Cheng, JT; Hsu, FL; Lin, CL; Liu, IM; Niu, HS, 2008
)
1.38
"The treatment of syringin intensely reduced the increased IgE, inflammatory cytokines, WBC count and restored the antioxidant stress markers OVA stimulated animals."( Syringin alleviates ovalbumin-induced lung inflammation in BALB/c mice asthma model via NF-κB signaling pathway.
Dai, R; Niu, M; Wang, N; Wang, Y, 2021
)
2.39
"Treatment with syringin showed significant dose-dependent inhibition of blood vessel length and junctions in the CAM of duck eggs; the anti-angiogenic activity of syringin at 100 µM and 200 µM is comparable with 200 µM of the positive control celecoxib. "( In Ovo and In Silico Evaluation of the Anti-Angiogenic Potential of Syringin.
Aventurado, CA; Billones, JB; Castillo, AL; Vasquez, RD, 2020
)
1.15

Pharmacokinetics

ExcerptReferenceRelevance
" This method was validated for specificity, accuracy and precision and was successfully applied to the pharmacokinetic study of syringin and chlorogenic acid in rat plasma after intravenous administration of Aidi lyophilizer."( Determination and pharmacokinetic study of syringin and chlorogenic acid in rat plasma after administration of Aidi lyophilizer.
Bi, KS; Jia, Y; Li, Q; Shen, ZD; Sun, LX; Wang, ZW; Xu, L, 2006
)
0.8
" The purpose of this study was to develop an HPLC-UV method for simultaneous determination of harpagoside and cinnamic acid in rat plasma and investigate pharmacokinetic parameters of harpagoside and cinnamic acid after oral administration of xuanshen extract (760 mg kg(-1))."( Simultaneous determination of harpagoside and cinnamic acid in rat plasma by high-performance liquid chromatography: application to a pharmacokinetic study.
Jin, X; Li, P; Xiao, L; Yang, K; Zhang, Y, 2007
)
0.34
"0 software was applied to calculate the pharmacokinetic parameters while the SPSS 17."( [Comparative pharmacokinetics of syringin, eleutheroside E and isofraxidin in rat plasma after intravenous administration of each monomer and Ciwujia injection].
Deng, ZP; Fan, HX; Xu, XT; Yao, QQ; Zhong, H, 2014
)
0.68

Bioavailability

ExcerptReferenceRelevance
" In order to solve the allergic reactions, side effects, and low oral bioavailability of eleutheroside B, we successfully prepared PLGA (poly [lactic-co-glycolic acid])-eleutheroside B nanoparticles (NPs) with the diameter of about 128 nm."( Eleutheroside B-loaded poly (lactic-co-glycolic acid) nanoparticles protect against renal fibrosis via Smad3-dependent mechanism.
Chen, X; Jin, R; Kan, M; Liu, Q; Meng, X; Pu, T; Xing, T; Yang, J; Yang, Y; Zang, H, 2021
)
0.62

Dosage Studied

ExcerptRelevanceReference
"Sixty female ICR mice were randomly assigned into sham operated group (SHAM, treated with vehicle) and five ovariectomized subgroups (n = 10 each), treated with vehicle as OVX group, estradiol valerate (EV, 1 mg/kg/day) as positive group, and Syringin (10, 20 and 40 mg/kg/day) as low, moderate and high dosage groups."( Syringin prevents bone loss in ovariectomized mice via TRAF6 mediated inhibition of NF-κB and stimulation of PI3K/AKT.
Dong, Y; Guo, Q; Liu, J; Ma, X; Zhang, Z; Zhao, Q, 2018
)
2.11
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
hepatoprotective agentAny compound that is able to prevent damage to the liver.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (4)

ClassDescription
beta-D-glucosideAny D-glucoside in which the anomeric centre has beta-configuration.
monosaccharide derivativeA carbohydrate derivative that is formally obtained from a monosaccharide.
primary alcoholA primary alcohol is a compound in which a hydroxy group, -OH, is attached to a saturated carbon atom which has either three hydrogen atoms attached to it or only one other carbon atom and two hydrogen atoms attached to it.
dimethoxybenzeneAny methoxybenzene that consists of a benzene skeleton substituted with two methoxy groups and its derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
monolignol glucosides biosynthesis111

Protein Targets (6)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Beta-lactamaseEscherichia coli K-12Potency89.12510.044717.8581100.0000AID485294
importin subunit beta-1 isoform 1Homo sapiens (human)Potency8.19955.804836.130665.1308AID540253
snurportin-1Homo sapiens (human)Potency8.19955.804836.130665.1308AID540253
GTP-binding nuclear protein Ran isoform 1Homo sapiens (human)Potency8.19955.804816.996225.9290AID540253
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Ribonuclease HIEscherichia coli K-12IC50 (µMol)20.00002.00002.25002.5000AID594714
Prostaglandin G/H synthase 1Homo sapiens (human)IC50 (µMol)36.00000.00021.557410.0000AID403341
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (8)

Processvia Protein(s)Taxonomy
DNA replication, removal of RNA primerRibonuclease HIEscherichia coli K-12
RNA catabolic processRibonuclease HIEscherichia coli K-12
DNA replication, removal of RNA primerRibonuclease HIEscherichia coli K-12
prostaglandin biosynthetic processProstaglandin G/H synthase 1Homo sapiens (human)
response to oxidative stressProstaglandin G/H synthase 1Homo sapiens (human)
regulation of blood pressureProstaglandin G/H synthase 1Homo sapiens (human)
cyclooxygenase pathwayProstaglandin G/H synthase 1Homo sapiens (human)
regulation of cell population proliferationProstaglandin G/H synthase 1Homo sapiens (human)
cellular oxidant detoxificationProstaglandin G/H synthase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (10)

Processvia Protein(s)Taxonomy
magnesium ion bindingRibonuclease HIEscherichia coli K-12
nucleic acid bindingRibonuclease HIEscherichia coli K-12
endonuclease activityRibonuclease HIEscherichia coli K-12
RNA-DNA hybrid ribonuclease activityRibonuclease HIEscherichia coli K-12
protein bindingRibonuclease HIEscherichia coli K-12
metal ion bindingRibonuclease HIEscherichia coli K-12
peroxidase activityProstaglandin G/H synthase 1Homo sapiens (human)
prostaglandin-endoperoxide synthase activityProstaglandin G/H synthase 1Homo sapiens (human)
protein bindingProstaglandin G/H synthase 1Homo sapiens (human)
heme bindingProstaglandin G/H synthase 1Homo sapiens (human)
metal ion bindingProstaglandin G/H synthase 1Homo sapiens (human)
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygenProstaglandin G/H synthase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (7)

Processvia Protein(s)Taxonomy
cytoplasmRibonuclease HIEscherichia coli K-12
photoreceptor outer segmentProstaglandin G/H synthase 1Homo sapiens (human)
cytoplasmProstaglandin G/H synthase 1Homo sapiens (human)
endoplasmic reticulum membraneProstaglandin G/H synthase 1Homo sapiens (human)
Golgi apparatusProstaglandin G/H synthase 1Homo sapiens (human)
intracellular membrane-bounded organelleProstaglandin G/H synthase 1Homo sapiens (human)
extracellular exosomeProstaglandin G/H synthase 1Homo sapiens (human)
cytoplasmProstaglandin G/H synthase 1Homo sapiens (human)
neuron projectionProstaglandin G/H synthase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (58)

Assay IDTitleYearJournalArticle
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID735308Antiinflammatory activity in C57BL/6 mouse BMDCs assessed as inhibition of LPS-stimulated TNF-alpha production treated 1 hr before LPS challenge measured 18 hrs post stimulation by ELISA2013Journal of natural products, Apr-26, Volume: 76, Issue:4
Diarylheptanoids and flavonoids from viscum album inhibit LPS-stimulated production of pro-inflammatory cytokines in bone marrow-derived dendritic cells.
AID594717Inhibition of HIV2 recombinant ribonuclease H after 30 mins by FRET quenching assay2011Bioorganic & medicinal chemistry letters, May-15, Volume: 21, Issue:10
New monoterpene glycosides and phenolic compounds from Distylium racemosum and their inhibitory activity against ribonuclease H.
AID1126475Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production at 0.4 uM after 18 hrs by griess reaction analysis2014Bioorganic & medicinal chemistry letters, Apr-15, Volume: 24, Issue:8
Anti-inflammatory components of Euphorbia humifusa Willd.
AID1056520Antiinflammatory activity in rat polymorphonuclear leukocytes assessed as inhibition of PAF-induced release of glucuronidase at 10 uM2013Journal of natural products, Dec-27, Volume: 76, Issue:12
Homosecoiridoid alkaloids with amino acid units from the flower buds of Lonicera japonica.
AID1370495Inhibition of Saccharomyces cerevisiae alpha-glucosidase using p-nitro-phenyl-alpha-D-glucopyranoside as substrate preincubated with enzyme followed by substrate addition measured after 10 mins for every 2.5 to 5 mins2018Bioorganic & medicinal chemistry letters, 02-01, Volume: 28, Issue:3
Chemical constituents from Taraxacum officinale and their α-glucosidase inhibitory activities.
AID403341Inhibition of COX12005Journal of natural products, Jul, Volume: 68, Issue:7
Expanding the ChemGPS chemical space with natural products.
AID311630Cytotoxicity against human HeLa cells by MTT assay2007Journal of natural products, Oct, Volume: 70, Issue:10
Cytotoxic lignans from the stem bark of Magnolia officinalis.
AID551461Antioxidant activity assessed as peroxyl radical scavenging activity at 1 to 2 uM by ORAC assay2011Bioorganic & medicinal chemistry letters, Jan-15, Volume: 21, Issue:2
Antioxidant activity of a new C-glycosylflavone from the leaves of Ficus microcarpa.
AID1056515Cytotoxicity against human Ketr3 cells at 10 uM after 96 hrs by MTT assay2013Journal of natural products, Dec-27, Volume: 76, Issue:12
Homosecoiridoid alkaloids with amino acid units from the flower buds of Lonicera japonica.
AID735305Cytotoxicity against C57BL/6 mouse BMDCs at 2 to 50 microM by MTT assay2013Journal of natural products, Apr-26, Volume: 76, Issue:4
Diarylheptanoids and flavonoids from viscum album inhibit LPS-stimulated production of pro-inflammatory cytokines in bone marrow-derived dendritic cells.
AID1176144Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-stimulated nitric oxide production at 0.4 to 10 uM after 24 hrs by Griess assay2015Bioorganic & medicinal chemistry letters, Jan-15, Volume: 25, Issue:2
Anti-inflammatory components of Chrysanthemum indicum flowers.
AID311632Cytotoxicity against human K562 cells by MTT assay2007Journal of natural products, Oct, Volume: 70, Issue:10
Cytotoxic lignans from the stem bark of Magnolia officinalis.
AID1056519Cytotoxicity against human A549 cells at 10 uM after 96 hrs by MTT assay2013Journal of natural products, Dec-27, Volume: 76, Issue:12
Homosecoiridoid alkaloids with amino acid units from the flower buds of Lonicera japonica.
AID1056514Cytotoxicity against human HCT8 cells at 10 uM after 96 hrs by MTT assay2013Journal of natural products, Dec-27, Volume: 76, Issue:12
Homosecoiridoid alkaloids with amino acid units from the flower buds of Lonicera japonica.
AID1126476Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNF-alpha secretion at 10 uM after 18 hrs by sandwich ELISA2014Bioorganic & medicinal chemistry letters, Apr-15, Volume: 24, Issue:8
Anti-inflammatory components of Euphorbia humifusa Willd.
AID1654523Cytotoxicity against mouse RAW264.7 cells assessed as reduction in cell viability at 6.25 to 100 uM after 24 hrs by EZ-Cytox cell viability assay
AID1126473Cytotoxicity against mouse RAW264.7 cells assessed as cell viability at 50 uM after 18 hrs by MTT assay in presence of LPS2014Bioorganic & medicinal chemistry letters, Apr-15, Volume: 24, Issue:8
Anti-inflammatory components of Euphorbia humifusa Willd.
AID594715Inhibition of human recombinant ribonuclease H after 30 mins by FRET quenching assay2011Bioorganic & medicinal chemistry letters, May-15, Volume: 21, Issue:10
New monoterpene glycosides and phenolic compounds from Distylium racemosum and their inhibitory activity against ribonuclease H.
AID1176142Cytotoxicity against mouse RAW264.7 cells at 50 uM by MTT assay2015Bioorganic & medicinal chemistry letters, Jan-15, Volume: 25, Issue:2
Anti-inflammatory components of Chrysanthemum indicum flowers.
AID594716Inhibition of HIV1 recombinant ribonuclease H after 30 mins by FRET quenching assay2011Bioorganic & medicinal chemistry letters, May-15, Volume: 21, Issue:10
New monoterpene glycosides and phenolic compounds from Distylium racemosum and their inhibitory activity against ribonuclease H.
AID1056518Cytotoxicity against human BGC823 cells at 10 uM after 96 hrs by MTT assay2013Journal of natural products, Dec-27, Volume: 76, Issue:12
Homosecoiridoid alkaloids with amino acid units from the flower buds of Lonicera japonica.
AID1126471Inhibition of sEH (unknown origin) assessed as substrate PHOME hydrolysis at 25 uM after 1 hr by fluorescence method2014Bioorganic & medicinal chemistry letters, Apr-15, Volume: 24, Issue:8
Anti-inflammatory components of Euphorbia humifusa Willd.
AID594714Inhibition of Escherichia coli recombinant ribonuclease H after 30 mins by FRET quenching assay2011Bioorganic & medicinal chemistry letters, May-15, Volume: 21, Issue:10
New monoterpene glycosides and phenolic compounds from Distylium racemosum and their inhibitory activity against ribonuclease H.
AID551462Antioxidant activity assessed as copper ion radical scavenging activity at 2 uM2011Bioorganic & medicinal chemistry letters, Jan-15, Volume: 21, Issue:2
Antioxidant activity of a new C-glycosylflavone from the leaves of Ficus microcarpa.
AID1176146Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-stimulated TNFalpha production at 10 uM by ELISA2015Bioorganic & medicinal chemistry letters, Jan-15, Volume: 25, Issue:2
Anti-inflammatory components of Chrysanthemum indicum flowers.
AID1126474Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production at 10 uM after 18 hrs by griess reaction analysis2014Bioorganic & medicinal chemistry letters, Apr-15, Volume: 24, Issue:8
Anti-inflammatory components of Euphorbia humifusa Willd.
AID355139Inhibition of nitric oxides synthase in mouse J774.1 cells assessed as inhibition of LPS-induced NO release at 100 ug/mL after 48 hrs by Griess assay relative to control1996Journal of natural products, Dec, Volume: 59, Issue:12
Syringin 4-O-beta-glucoside, a new phenylpropanoid glycoside, and costunolide, a nitric oxide synthase inhibitor, from the stem bark of Magnolia sieboldii.
AID311631Cytotoxicity against human A549 cells by MTT assay2007Journal of natural products, Oct, Volume: 70, Issue:10
Cytotoxic lignans from the stem bark of Magnolia officinalis.
AID1056517Cytotoxicity against human MCF7 cells at 10 uM after 96 hrs by MTT assay2013Journal of natural products, Dec-27, Volume: 76, Issue:12
Homosecoiridoid alkaloids with amino acid units from the flower buds of Lonicera japonica.
AID1781911Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production pretreated with compound for 2 hrs followed by LPS stimulation measured after 18 hrs by gGriess reagent based assay2021Journal of natural products, 11-26, Volume: 84, Issue:11
Total Syntheses and Anti-inflammatory Activities of Syringin and Its Natural Analogues.
AID1781910Cytotoxicity against mouse RAW264.7 cells assessed as reduction in cell viability at 100 uM measured after 24 hrs by MTT assay2021Journal of natural products, 11-26, Volume: 84, Issue:11
Total Syntheses and Anti-inflammatory Activities of Syringin and Its Natural Analogues.
AID436320Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production after 24 hrs2008Journal of natural products, Nov, Volume: 71, Issue:11
Phenylpropanoids from Daphne feddei and their inhibitory activities against NO production.
AID551463Metal chelating activity of the compound at 1 to 2 uM2011Bioorganic & medicinal chemistry letters, Jan-15, Volume: 21, Issue:2
Antioxidant activity of a new C-glycosylflavone from the leaves of Ficus microcarpa.
AID1176148Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-stimulated TNFalpha production at 0.4 to 2 uM by ELISA2015Bioorganic & medicinal chemistry letters, Jan-15, Volume: 25, Issue:2
Anti-inflammatory components of Chrysanthemum indicum flowers.
AID625306Antioxidant activity assessed as superoxide radical scavenging activity after 20 mins by spectrophotometric analysis2011Bioorganic & medicinal chemistry letters, Nov-01, Volume: 21, Issue:21
Secoiridoid glucosides and related compounds from Syringa reticulata and their antioxidant activities.
AID1370496Inhibition of Saccharomyces cerevisiae alpha-glucosidase using p-nitro-phenyl-alpha-D-glucopyranoside as substrate at 200 uM preincubated with enzyme followed by substrate addition measured after 10 mins for every 2.5 to 5 mins relative to control2018Bioorganic & medicinal chemistry letters, 02-01, Volume: 28, Issue:3
Chemical constituents from Taraxacum officinale and their α-glucosidase inhibitory activities.
AID1126479Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNF-alpha secretion after 18 hrs by sandwich ELISA2014Bioorganic & medicinal chemistry letters, Apr-15, Volume: 24, Issue:8
Anti-inflammatory components of Euphorbia humifusa Willd.
AID1126477Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNF-alpha secretion at 0.4 uM after 18 hrs by sandwich ELISA2014Bioorganic & medicinal chemistry letters, Apr-15, Volume: 24, Issue:8
Anti-inflammatory components of Euphorbia humifusa Willd.
AID1056516Cytotoxicity against human Bel7402 cells at 10 uM after 96 hrs by MTT assay2013Journal of natural products, Dec-27, Volume: 76, Issue:12
Homosecoiridoid alkaloids with amino acid units from the flower buds of Lonicera japonica.
AID735306Antiinflammatory activity in C57BL/6 mouse BMDCs assessed as inhibition of LPS-stimulated IL-12p40 production treated 1 hr before LPS challenge measured 18 hrs post stimulation by ELISA2013Journal of natural products, Apr-26, Volume: 76, Issue:4
Diarylheptanoids and flavonoids from viscum album inhibit LPS-stimulated production of pro-inflammatory cytokines in bone marrow-derived dendritic cells.
AID735307Antiinflammatory activity in C57BL/6 mouse BMDCs assessed as inhibition of LPS-stimulated IL12 production treated 1 hr before LPS challenge measured 18 hrs post stimulation by ELISA2013Journal of natural products, Apr-26, Volume: 76, Issue:4
Diarylheptanoids and flavonoids from viscum album inhibit LPS-stimulated production of pro-inflammatory cytokines in bone marrow-derived dendritic cells.
AID333687Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins2004Journal of natural products, Dec, Volume: 67, Issue:12
New furofuran and butyrolactone lignans with antioxidant activity from the stem bark of Styrax japonica.
AID1056513Antiviral activity against HIV1 infected in human 293T cells expressing VSV-G assessed as inhibition of viral p24 production at 10 uM after 48 hrs by ELISA2013Journal of natural products, Dec-27, Volume: 76, Issue:12
Homosecoiridoid alkaloids with amino acid units from the flower buds of Lonicera japonica.
AID625307Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins by spectrophotometric analysis2011Bioorganic & medicinal chemistry letters, Nov-01, Volume: 21, Issue:21
Secoiridoid glucosides and related compounds from Syringa reticulata and their antioxidant activities.
AID1126478Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production after 18 hrs by griess reaction analysis2014Bioorganic & medicinal chemistry letters, Apr-15, Volume: 24, Issue:8
Anti-inflammatory components of Euphorbia humifusa Willd.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (148)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (2.70)18.7374
1990's9 (6.08)18.2507
2000's40 (27.03)29.6817
2010's59 (39.86)24.3611
2020's36 (24.32)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 33.98

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index33.98 (24.57)
Research Supply Index5.03 (2.92)
Research Growth Index5.23 (4.65)
Search Engine Demand Index47.56 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (33.98)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (0.66%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other151 (99.34%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]